Clinical Trial Update: Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating multiple doses of sirolimus for cystic lymphatic malformations is currently recruiting for Phase 2 and Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Malformation

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: West China Hospital | Conditions: Lymphatic Malformation | Phase 2, Phase 3 | Status: RECRUITING